New-Onset Diabetes After Renal Transplantation
暂无分享,去创建一个
[1] C. Legendre,et al. The ORION Study: Comparison of Two Sirolimus‐Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] D. Min,et al. Genetic and Clinical Risk Factors of New-Onset Diabetes After Transplantation in Hispanic Kidney Transplant Recipients , 2011, Transplantation.
[3] M. Droździk,et al. Association of transcription factor 7-like 2 (TCF7L2) gene polymorphism with posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus , 2011, Pharmacological reports : PR.
[4] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[5] A. Geerts,et al. Hypomagnesemia and the risk of new‐onset diabetes after liver transplantation , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] Valerie Teal,et al. Association of Metabolic Syndrome With Development of New-Onset Diabetes After Transplantation , 2010, Transplantation.
[7] M. Arias,et al. Influence of interleukin-6 promoter polymorphism -174 g/c on kidney graft outcome. , 2010, Transplantation proceedings.
[8] Ayellet V. Segrè,et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.
[9] A. Hartmann,et al. Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[10] A. Hartmann,et al. Glucose tolerance before and after renal transplantation. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] J. Campistol,et al. A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study) , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] A. Sharif,et al. Diagnostic application of the A(1c) assay in renal disease. , 2010, Journal of the American Society of Nephrology : JASN.
[13] L. Rostaing,et al. A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study) , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] Ethan M Balk,et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.
[15] S. Humphries,et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study , 2010, BMJ : British Medical Journal.
[16] M. Droździk,et al. Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus , 2010, The Pharmacogenomics Journal.
[17] J. Cerhan,et al. Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation. , 2009, Transplantation proceedings.
[18] D. Abramowicz,et al. TCF7L2 polymorphism associates with new-onset diabetes after transplantation. , 2009, Journal of the American Society of Nephrology : JASN.
[19] M. Kim,et al. Association of Common Type 2 Diabetes Risk Gene Variants and Posttransplantation Diabetes Mellitus in Renal Allograft Recipients in Korea , 2009, Transplantation.
[20] W. van Biesen,et al. Posttransplantation Hypomagnesemia and Its Relation with Immunosuppression as Predictors of New‐Onset Diabetes after Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] A. Hartmann,et al. Fasting Plasma Glucose and Glycosylated Hemoglobin in the Screening for Diabetes Mellitus After Renal Transplantation , 2009, Transplantation.
[22] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[23] J. Squifflet,et al. Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. , 2009, Journal of the American Society of Nephrology : JASN.
[24] J. Pankow,et al. Serological evidence of infections and Type 2 diabetes: the Multiethnic Study of Atherosclerosis , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[25] L. Hilbrands,et al. Reduced exposure to calcineurin inhibitors in renal transplantation. , 2008, The New England journal of medicine.
[26] A. Webster,et al. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. , 2008, Journal of the American Society of Nephrology : JASN.
[27] W. Winkelmayer,et al. Pottransplantation anemia: management and rationale. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[28] A. Pittas,et al. Management of glycemia in patients with diabetes mellitus and CKD. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] D. Abramowicz,et al. Conversion from tacrolimus to cyclosporine A for new‐onset diabetes after transplantation: a single‐centre experience in renal transplanted patients and review of the literature , 2007, Transplant international : official journal of the European Society for Organ Transplantation.
[30] Peter Almgren,et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. , 2007, The Journal of clinical investigation.
[31] S. Chadban,et al. Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[32] M. Schnitzler,et al. Diabetic Complications Associated With New-Onset Diabetes Mellitus in Renal Transplant Recipients , 2007, Transplantation.
[33] T. Shah,et al. Risk Factors for Development of New-Onset Diabetes Mellitus After Kidney Transplantation , 2006, Transplantation.
[34] J. Neilson,et al. Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function , 2006, Nature.
[35] M. Deschamps,et al. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. , 2006, Journal of the American Society of Nephrology : JASN.
[36] E. Salido,et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] M. Barbagallo,et al. Serum Ionized Magnesium Levels in Relation to Metabolic Syndrome in Type 2 Diabetic Patients , 2006, Journal of the American College of Nutrition.
[38] L. Shaw,et al. Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation , 2006, Therapeutic drug monitoring.
[39] M. Bakkaloğlu,et al. The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation. , 2006, Transplantation proceedings.
[40] A. Hartmann,et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. , 2006, Kidney international.
[41] T. Habuchi,et al. Clinical and Genetic Risk Factors for Posttransplant Diabetes Mellitus in Adult Renal Transplant Recipients Treated with Tacrolimus , 2005, Transplantation.
[42] F. Bandrés,et al. Association of the genetic polymorphisms of the renin-angiotensin system with kidney graft long-term outcome: preliminary results. , 2005, Transplantation proceedings.
[43] S. Puumala,et al. New-Onset Diabetes after Kidney Transplantation: An Application of 2003 International Guidelines , 2005, Transplantation.
[44] S. di Paolo,et al. Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. , 2005, Journal of the American Society of Nephrology : JASN.
[45] A. Webster,et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data , 2005, BMJ : British Medical Journal.
[46] T. Larson,et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. , 2005, Kidney international.
[47] M. Schnitzler,et al. Guidelines for the treatment and management of new‐onset diabetes after transplantation 1 , 2005, Clinical transplantation.
[48] E. Benedetti,et al. Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitus. , 2005, Transplantation proceedings.
[49] T. Egeland,et al. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation , 2004, Diabetologia.
[50] H. Volk,et al. Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants. , 2004, Kidney international.
[51] R. Balshaw,et al. New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta‐Analysis , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[52] J. Shaw,et al. Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.
[53] M. Schnitzler. Diabetes Mellitus After Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[54] L. Pączek,et al. Posttransplantation diabetus mellitus under calcineurin inhibitor. , 2003, Transplantation proceedings.
[55] L. Rostaing,et al. Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. , 2003, Journal of the American Society of Nephrology : JASN.
[56] M. Rosenkoetter. International expert panel. , 2003, Nursing outlook.
[57] C.,et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. , 2003, Transplantation.
[58] M. Schnitzler,et al. Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait‐Listed and Transplanted Renal Allograft Recipients , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[59] M. Rodríguez-Moran,et al. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. , 2003, Diabetes care.
[60] M. Rodríguez-Moran,et al. Low serum magnesium levels and metabolic syndrome , 2002, Acta Diabetologica.
[61] K. Brayman,et al. Neoral® rescue therapy in transplant patients with intolerance to tacrolimus , 2002, Clinical transplantation.
[62] M. Arias,et al. Apolipoprotein C‐III and E Polymorphisms and Cardiovascular Syndrome, Hyperlipidemia, and Insulin Resistance in Renal Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[63] C. Mathieu,et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. , 2001, Transplantation.
[64] B. Wolffenbuttel,et al. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. , 2001, Journal of the American Society of Nephrology : JASN.
[65] Hyun Chul Lee,et al. Identification of glucokinase mutation in subjects with post-renal transplantation diabetes mellitus. , 2000, Diabetes research and clinical practice.
[66] N. Ozdemir,et al. Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients. , 2000, Transplantation proceedings.
[67] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[68] T. Egeland,et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. , 1997, Transplantation.
[69] N. Al-Akash. Diabetes mellitus after kidney transplantation. , 1995, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[70] T. Fujimura,et al. TRANSCRIPTIONAL INHIBITION OF INSULIN BY FK506 AND POSSIBLE INVOLVEMENT OF FK506 BINDING PROTEIN‐12 IN PANCREATIC β-CELL , 1995, Transplantation.
[71] J. Habener,et al. Wnt signaling in pancreatic islets. , 2010, Advances in experimental medicine and biology.
[72] B. Krüger,et al. Reduced exposure to calcineurin inhibitors in renal transplantation. , 2008, The New England journal of medicine.
[73] J. Neilson,et al. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. , 2006, Nature.